Nipro Europe Group Companies

Makoto-intravascular-imaging-system

Nipro intravascular imaging is committed to advancing the diagnosis and management of coronary artery disease around the world. We are building on the work developed by Infraredx, a Nipro company that has 30 years of research on the association between heart attacks and lipid core plaques. With a bold vision pioneering the design, manufacture, and distribution of technologies that addresses the needs of practitioners and improves outcomes for patients with coronary artery disease.

Achieve unparalleled insights with the Dualpro™ IVUS+NIRS catheter and its accompanying Makoto™ Intravascular Imaging System- the only CE Marked and FDA-cleared dual-modality catheter and imaging system indicated for the detection of lipid core plaque (LCP) and the identification of plaque and patients at higher risk of major adverse cardiovascular events (MACE).